Atlas Trials

Renal Mechanism of SGLT2 Inhibition

Clinical trial NCT05507892 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05507892
Sponsor
University of Colorado, Denver
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 DiabetesDiabetic Kidney Disease
Start date
2022-10-10
Primary completion
2026-12-15
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.